U.S. Reps. Jack Bergman (R-Mich.) and Donald Davis' (D-N.C.) Sept. 17 resolution stated that FQHCs “should continue to operate under their longstanding, single patient definition for all services, including drugs purchased under the 340B drug pricing program.”
Bipartisan House Duo’s Resolution Backs CHC Patient Definition
U.S. House lawmakers left Washington, D.C., earlier than expected last week, delaying expected developments on 340B-related bills—and a new resolution—until [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.